Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesIntuitive Surgical Inc

Intuitive Surgical Inc

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
440.75 USD 3.88 ( 0.89%)
Last update at 2026-11-03T21:08:00Z
VOLUME
1699164
Market Cap
135128.15M
P/E
43.30

Momentum Score

…

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
434.05
Low
443.58
High
52 Week Price Range
328.57
Low
603.88
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Intuitive Surgical makes robotic surgical systems with instruments, software and services that support minimally invasive procedures and recurring consumable revenue. Long-term growth may be supported by wider clinical adoption, expansion into new procedures and steady aftermarket revenue from instruments, service and software, and the company appears positioned as an industry leader with a large installed base, high-margin recurring sales and sustained R&D.
Principal risks include intensifying competition, regulatory and reimbursement changes, dependence on hospital capital spending and procedure volumes, and product-liability or supply-chain disruptions that could impair adoption or margins.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
436.87
Dividend Yield
-
Revenue TTM
11034.40M
Revenue Per Share
31.07
Gross Profit TTM
7357.60M
Debt / Equity
0.02
ROE
17.42%
Net Debt
-3065.20M
ROCE
17.78%
Diluted EPS TTM
8.71

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 3311.40M 2673.80M 1958.90M 1606.80M 1890.30M
Minority interest -20.60M -14.90M -19.30M -22.10M -23.50M
Net income 2856.00M 2322.60M 1798.00M 1322.30M 1704.60M
Selling general administrative 2385.00M 2140.00M 1963.90M 1739.90M 1466.50M
Gross profit 6642.30M 5634.20M 4729.50M 4196.00M 3958.50M
Reconciled depreciation 677.10M 462.00M 421.80M 365.80M 310.20M
Ebit 3311.40M 2673.80M 1958.90M 1211.30M 1510.80M
Ebitda 3988.50M 3135.80M 2361.10M 1577.10M 1821.00M
Depreciation and amortization 677.10M 462.00M 402.20M 365.80M 310.20M
Non operating income net other - - - 29.70M 69.30M
Operating income 2945.50M 2348.90M 1766.80M 1211.30M 1821.00M
Other operating expenses 7119.20M 6003.20M 5357.30M 4645.10M 3889.10M
Interest expense - - - 29.70M 356.00M
Tax provision 434.80M 336.30M 141.60M 262.40M 162.20M
Interest income 365.90M 324.90M 192.10M 29.70M 69.30M
Net interest income 365.90M 324.90M 192.10M 29.70M 69.30M
Income tax expense 434.80M 336.30M 141.60M 262.40M 162.20M
Total revenue 10064.70M 8352.10M 7124.10M 6222.20M 5710.10M
Total operating expenses 3696.80M 3285.30M 2962.70M 2618.90M 2137.50M
Cost of revenue 3422.40M 2717.90M 2394.60M 2026.20M 1751.60M
Total other income expense net 365.90M 324.90M 192.10M 395.50M 69.30M
Net income from continuing ops 2876.60M 2337.50M 1817.30M 1344.40M 1728.10M
Net income applicable to common shares - - - 1322.30M 1704.60M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 20631.20M 18838.60M 15441.50M 12974.00M 13555.00M
Intangible assets 11.10M 23.00M 636.70M 49.80M 70.50M
Other current assets 376.40M 253.70M 176.70M 164.30M 271.10M
Total liab 2689.50M 2309.00M 2044.20M 1861.40M 1603.50M
Total stockholder equity 17824.00M 16433.70M 13307.60M 11112.60M 11951.50M
Deferred long term liab - - - 72.30M 71.80M
Other current liab 1080.00M 1049.60M 998.60M 1276.10M 1068.30M
Common stock 0.40M 0.40M 0.40M 0.40M 0.40M
Capital stock 0.40M 0.40M 0.40M 0.40M 0.40M
Retained earnings 7011.80M 6803.30M 4743.00M 3500.10M 4760.90M
Other liab - - - 369.70M 414.00M
Good will 370.30M 347.50M 348.70M 348.50M 343.60M
Other assets - - - 1183.60M 13555.00M
Cash 3368.00M 2027.40M 2750.10M 1581.20M 1290.90M
Total current liabilities 2006.20M 1745.30M 1658.70M 1861.40M 1603.50M
Current deferred revenue 506.70M 468.80M 446.10M 438.30M 414.00M
Net debt -3065.20M -1881.40M -2660.30M -1581.20M -1203.90M
Short term debt 39.00M 33.50M 25.30M - -
Short long term debt total 302.80M 146.00M 89.80M - 87.00M
Other stockholder equity 10768.50M 9681.30M 8576.40M 7774.60M 7214.40M
Property plant equipment - - - 2374.20M 1876.40M
Total current assets 9779.50M 7111.00M 7888.00M 8576.80M 9989.30M
Long term investments 3099.20M 4819.10M 2120.00M 2623.60M 4415.50M
Net tangible assets - - - 9983.30M 11607.90M
Short term investments 2566.90M 1985.90M 2473.10M 2541.00M 2940.00M
Net receivables 1628.20M 1356.80M 1267.50M 942.10M 782.70M
Inventory 1840.00M 1487.20M 1220.60M 893.20M 587.10M
Accounts payable 255.10M 193.40M 188.70M 147.00M 121.20M
Noncontrolling interest in consolidated entity - - - 70.70M 50.40M
Accumulated other comprehensive income 43.30M -51.30M -12.20M -162.50M -24.20M
Common stock total equity - - - 0.40M 0.40M
Retained earnings total equity - - - 3500.10M 4760.90M
Non currrent assets other 810.80M 369.00M 597.60M -1613.70M -3511.20M
Non current assets total 10851.70M 11727.60M 7553.50M 4397.20M 3565.70M
Capital lease obligations - - - - 87.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 1219.50M -3272.80M 1258.90M 1916.00M -2099.30M
Change to liabilities - - - 216.00M 235.10M
Total cashflows from investing activities 665.80M -3272.80M - 1370.80M -2461.50M
Total cash from financing activities -2364.10M 150.90M -287.60M -2572.30M 43.00M
Change to operating activities - - - 44.00M -38.40M
Net income 2876.60M 2337.50M 1817.30M 1344.40M 1728.10M
Change in cash 1345.00M -707.70M 1169.40M 294.70M -332.50M
Begin period cash flow 2062.40M 2770.10M 1600.70M 1306.00M 1638.50M
End period cash flow 3407.40M 2062.40M 2770.10M 1600.70M 1306.00M
Total cash from operating activities 3030.50M 2415.00M 1813.80M 1490.80M 2089.40M
Depreciation 677.10M 462.00M 421.80M 365.80M 310.20M
Other cashflows from investing activities - -1.00M - -12.80M -8.70M
Dividends paid - 8.00M - - -
Change to inventory -1063.40M -830.00M -712.50M -546.60M -256.00M
Change to account receivables -301.70M -95.90M -186.30M -159.30M -142.30M
Sale purchase of stock -2295.30M 0.00M -416.30M -2607.40M -211.60M
Other cashflows from financing activities -419.10M -278.50M -167.60M -198.70M -21.90M
Change to netincome - - - 324.10M 386.60M
Capital expenditures 539.80M 1111.20M 1064.20M 532.40M 353.50M
Change receivables - - - -159.30M -142.30M
Cash flows other operating - - - 235.40M 99.90M
Exchange rate changes - - - - -3.40M
Cash and cash equivalents changes - - - 289.30M -332.50M
Change in working capital -1272.30M -919.30M -777.60M -619.10M -368.10M
Stock based compensation 788.20M 676.80M 592.80M 513.20M 449.20M
Other non cash items -58.20M -6.70M 40.30M 71.80M 32.60M
Free cash flow 2490.70M 1303.80M 749.60M 958.40M 1735.90M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ISRG
Intuitive Surgical Inc		 3.88
0.89%		 440.75 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme		 -2.00
0.95%		 208.00 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -1.89
1.80%		 103.04 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 -0.66
0.33%		 197.94 31.62 13.76 2.25 2.04 2.93 13.40
HOCPF
HOYA Corporation		 -8.51
5.07%		 159.30 29.74 26.60 0.05 7.23 7.02 18.02

Profile*

Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304

408 523 2100

https://www.intuitive.com

17021

Name Title Year Born
Dr. Gary S. Guthart Ph.D. Pres, CEO & Director 1966
Mr. Marshall L. Mohr Exec. VP of Global Bus. Services 1956
Mr. David J. Rosa Exec. VP and Chief Strategy & Growth Officer 1968
Dr. Myriam J. Curet McAdams F.A.C.S., M.D. Exec. VP & Chief Medical Officer 1957
Mr. Robert DeSantis Exec. VP & Chief Product Officer 1966
Mr. Jamie E. Samath Sr. VP & CFO 1971
Mr. Fredrik Widman VP, Principal Accounting Officer & Corp. Controller NA
Mr. Philip Kim Head of Investor Relations NA
Mr. Gary Loeb Gen. Counsel & Chief Compliance Officer NA
Mr. Julian Nikolchev Sr. VP of Corp. Devel. & Strategy 1954

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

VNP
CAD 32.54
+24.44%
HUT
CAD 88.32
+14.81%
KEEL
CAD 3.05
+14.66%
MTY
CAD 36.63
+13.58%
CNL
CAD 15.98
+11.90%
MOON
CAD 4.72
-12.34%
EU
CAD 0.96
-8.57%
URE
CAD 1.02
-8.48%
AP-UN
CAD 3.71
-8.17%
HG
CAD 3.77
-8.05%

Equity Sectors*

  • Basic Materials

    -1.14%

  • Communication Services

    +0.65%

  • Consumer Cyclical

    +0.09%

  • Consumer Defensive

    -0.57%

  • Energy

    -0.15%

  • Financial Services

    +0.08%

  • Healthcare

    +2.18%

  • Industrials

    +2.04%

  • Real Estate

    -0.25%

  • Technology

    +1.02%

  • Utilities

    +0.66%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…